Literature DB >> 23315266

Modification of proportion sensitivity testing method for ethionamide.

Rajagopalan Lakshmi1, Ranjani Ramachandran, K Devika, G Radhika, A Syam Sundar, Fathima Rahman, N Selvakumar, Vanaja Kumar.   

Abstract

Standardized methodology for drug susceptibility testing of second line drugs is vital for treatment of multi/extensively drug resistant tuberculosis. Discrepancy between laboratory methods and clinical interpretation is well established for bacteriostatic drugs such as ethionamide. Optimization of the standard proportion sensitivity testing (PST) method for ethionamide was under taken in 235 Mycobacterium tuberculosis isolates from new and previously treated pulmonary tuberculosis patients. An additional higher concentration of 57 μg/ml was evaluated against at the standard 40 μg/ml concentration in PST method. Performance parameters and agreement between the two drug concentrations was higher indicating the efficiency of PST method at its present format at 40 μg/ml and additional higher concentration of 57 μg/ml as an alternative when required.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23315266     DOI: 10.1007/s11274-013-1255-y

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  5 in total

Review 1.  Drug resistance in tuberculosis.

Authors:  D A Mitchison
Journal:  Eur Respir J       Date:  2005-02       Impact factor: 16.671

Review 2.  Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems.

Authors:  Claudio Piersimoni; Armando Olivieri; Luca Benacchio; Claudio Scarparo
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

3.  Comparison of methods for testing the sensitivity of Mycobacterium tuberculosis to ethionamide.

Authors:  M J Lefford; D A Mitchison
Journal:  Tubercle       Date:  1966-09

4.  Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes.

Authors:  G Canetti; W Fox; A Khomenko; H T Mahler; N K Menon; D A Mitchison; N Rist; N A Smelev
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

5.  Determination of critical concentrations of second-line anti-tuberculosis drugs with clinical and microbiological relevance.

Authors:  K M Kam; A Sloutsky; C W Yip; N Bulled; K J Seung; M Zignol; M Espinal; S J Kim
Journal:  Int J Tuberc Lung Dis       Date:  2010-03       Impact factor: 2.373

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.